Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 4/20 | 0.38 |
| ▸ | ATAD2 | Q6PL18 | 3/20 | 0.38 |
| ▸ | PIM1 | P11309 | 5/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 5/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1277831 | 1.00 | BRD4 (0.38) | BRD4ATAD2PIM1PIM2KDM4E | |
| SCHEMBL1278039 | 0.91 | BRD4 (0.36) | BRD4ATAD2PIM1PIM2 | |
| SCHEMBL1278037 | 0.91 | BRD4 (0.36) | BRD4ATAD2PIM1PIM2 | |
| SCHEMBL1278150 | 0.91 | BRD4 (0.38) | BRD4ATAD2PIM1PIM2 | |
| SCHEMBL1278146 | 0.91 | BRD4 (0.38) | BRD4ATAD2PIM1PIM2 | |
| SCHEMBL3025267 | 0.88 | BRD4 (0.39) | BRD4ATAD2PIM1PIM2KDM4E | |
| SCHEMBL3025264 | 0.88 | BRD4 (0.39) | BRD4ATAD2PIM1PIM2KDM4E | |
| SCHEMBL2930374 | 0.88 | BRD4 (0.41) | BRD4ATAD2PIM1PIM2KDM4E | |
| SCHEMBL1277663 | 0.88 | BRD4 (0.43) | BRD4ATAD2PIM1PIM2KDM4E | |
| SCHEMBL1277660 | 0.88 | BRD4 (0.43) | BRD4ATAD2PIM1PIM2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309586-B2 | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient | LG LIFE SCIENCES LTD. (KR) | 2012-11-13 | — | — | US | disclosed |
| US-20120088760-A1 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT | LG CHEM, LTD. (KR) | 2012-04-12 | — | — | US | disclosed |
| US-20100267708-A1 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT | LG LIFE SCIENCES LTD. (KR) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088760-A1 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT | GCKR, GCK, GALK1 | BRD4 4127/4885ATAD2 2604/4885PIM1 2476/4885 |
| US-20100267708-A1 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT | GCK, GCKR, HK1 | BRD4 3674/4885ATAD2 2052/4885PIM1 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.